Literature DB >> 32035166

Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Eric M Liotta1, W Taylor Kimberly2.   

Abstract

Liver disease is a growing public health concern. Hepatic encephalopathy, the syndrome of brain dysfunction secondary to liver disease, is a frequent complication of both acute and chronic liver disease and cerebral edema (CE) is a key feature. While altered ammonia metabolism is a key contributor to hepatic encephalopathy and CE in liver disease, there is a growing appreciation that additional mechanisms contribute to CE. In this review we will begin by presenting three classic perspectives that form a foundation for a discussion of CE in liver disease: 1) CE is unique to acute liver failure, 2) CE in liver disease is only cytotoxic, and 3) CE in liver disease is primarily an osmotically mediated consequence of ammonia and glutamine metabolism. We will present each classic perspective along with more recent observations that call in to question that classic perspective. After highlighting these areas of debate, we will explore the leading contemporary mechanisms hypothesized to contribute to CE during liver disease.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral edema; Cirrhosis; Hepatic encephalopathy; Liver failure

Mesh:

Substances:

Year:  2020        PMID: 32035166      PMCID: PMC7773170          DOI: 10.1016/j.neulet.2020.134818

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  172 in total

1.  Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.

Authors:  Faouzi Saliba; Christophe Camus; François Durand; Philippe Mathurin; Alexia Letierce; Bertrand Delafosse; Karl Barange; Pierre François Perrigault; Magali Belnard; Philippe Ichaï; Didier Samuel
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

2.  Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

Authors:  William Bernal; Anna Hyyrylainen; Amit Gera; Vinod K Audimoolam; Mark J W McPhail; Georg Auzinger; Mohammed Rela; Nigel Heaton; John G O'Grady; Julia Wendon; Roger Williams
Journal:  J Hepatol       Date:  2013-02-22       Impact factor: 25.083

Review 3.  Hyperosmolar therapy for raised intracranial pressure.

Authors:  Allan H Ropper
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

4.  Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes.

Authors:  G Bai; K V Rama Rao; C R Murthy; K S Panickar; A R Jayakumar; M D Norenberg
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

5.  Microglia activation in hepatic encephalopathy in rats and humans.

Authors:  Irina Zemtsova; Boris Görg; Verena Keitel; Hans-Jürgen Bidmon; Karsten Schrör; Dieter Häussinger
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

6.  Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure.

Authors:  Naoki Shimojima; Christopher B Eckman; Michael McKinney; Daniel Sevlever; Satoshi Yamamoto; Wenlang Lin; Dennis W Dickson; Justin H Nguyen
Journal:  J Invest Surg       Date:  2008 May-Jun       Impact factor: 2.533

7.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

8.  Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial-generated reactive oxygen species.

Authors:  A J Kowaltowski; R F Castilho; A E Vercesi
Journal:  FEBS Lett       Date:  1996-01-08       Impact factor: 4.124

9.  Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo.

Authors:  Boris Görg; Natalia Qvartskhava; Verena Keitel; Hans J Bidmon; Oliver Selbach; Freimut Schliess; Dieter Häussinger
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

10.  Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.

Authors:  Christopher Rose; Lars M Ytrebø; Nathan A Davies; Sambit Sen; Geir I Nedredal; Mireille Belanger; Arthur Revhaug; Rajiv Jalan
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

View more
  4 in total

1.  Mitochondrial Changes in Rat Brain Endothelial Cells Associated with Hepatic Encephalopathy: Relation to the Blood-Brain Barrier Dysfunction.

Authors:  Krzysztof Milewski; Karolina Orzeł-Gajowik; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2022-08-02       Impact factor: 4.414

2.  Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure.

Authors:  Stefan Chiriac; Carol Stanciu; Camelia Cojocariu; Ana-Maria Singeap; Catalin Sfarti; Tudor Cuciureanu; Irina Girleanu; Razvan Alexandru Igna; Anca Trifan
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

3.  Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis.

Authors:  Jian Fu; Yi Gao; Li Shi
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.240

4.  Retention enema with traditional Chinese medicine for hepatic encephalopathy: A protocol for a systematic review and meta-analysis.

Authors:  Xiao Liang; Lihong Wen; Yifang Wu; Yanmin Hao; Shaobo Wang; Xiaoyu Hu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.